Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Comment
  • Published:

Planning for the post-antibiotic era — why we must avoid TRUS-guided biopsy sampling

Health officials are warning that overuse of antibiotics and increasing antibiotic resistance mean that these drugs could soon become useless. Urologists have to take some responsibility as we continue to perform prostate biopsy sampling using a transrectal approach, which increases the possibility of bacterial infection.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

References

  1. Chan, M. Combat drug resistance: no action today means no cure tomorrow. WHO http://www.who.int/mediacentre/news/statements/2011/whd_20110407/en/ (2011).

  2. Wagenlehner, F. M., Pilatz, A., Waliszewski, P., Weidner, W. & Johansen, T. E. Reducing infection rates after prostate biopsy. Nat. Rev. Urol. 11, 80–86 (2014).

    Article  PubMed  Google Scholar 

  3. Wagenlehner, F. M. et al. Infective complications after prostate biopsy: outcome of the Global Prevalence Study of Infections in Urology (GPIU) 2010 and 2011, a prospective multinational multicentre prostate biopsy study. Eur. Urol. 63, 521–527 (2013).

    Article  PubMed  Google Scholar 

  4. Liss, M. A. et al. Fluoroquinolone resistant rectal colonization predicts risk of infectious complications after transrectal prostate biopsy. J. Urol. 192, 1673–1678 (2014).

    Article  PubMed  Google Scholar 

  5. Liss, M. A. et al. The prevention and treatment of the more common complications related to prostate biopsy. https://www.auanet.org/common/pdf/education/clinical-guidance/AUA-PNB-White-Paper.pdf (2016).

  6. Womble, P. R. et al. A statewide intervention to reduce hospitalizations after prostate biopsy. J. Urol. 194, 403–409 (2015).

    Article  PubMed  Google Scholar 

  7. Grummet, J. W. et al. Sepsis and 'superbugs': should we favour the transperineal over the transrectal approach for prostate biopsy? BJU Int. 114, 384–388 (2014).

    PubMed  Google Scholar 

  8. Chang, D. T., Challacombe, B. & Lawrentschuk, N. Transperineal biopsy of the prostate-is this the future? Nat. Rev. Urol. 10, 690–702 (2013).

    Article  PubMed  Google Scholar 

  9. DiBianco, J. M., Mullins, J. K. & Allaway, M. Ultrasound guided, freehand transperineal prostate biopsy: an alternative to the transrectal approach. Urol. Pract. 3, 134–140 (2016).

    Article  Google Scholar 

  10. DiBianco, M. J. & Allaway, M. Freehand transperineal prostate biopsy under local anaesthesia. J. Urol. 195, e466–e667 (2016).

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Declan G. Murphy.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Murphy, D., Grummet, J. Planning for the post-antibiotic era — why we must avoid TRUS-guided biopsy sampling. Nat Rev Urol 13, 559–560 (2016). https://doi.org/10.1038/nrurol.2016.176

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrurol.2016.176

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing